First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...
The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.
U.S. FDA accepts and grants Priority Review for the Biologics License Application for ifinatamab deruxtecan. The application ...
Is Zepzelca Right for Me? To help choose the right treatment for you, your health care provider will consider what type of lung cancer you have, the treatments you have received, and whether the ...
Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with ...
Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs).
Dr. Zhonglin Hao says small cell lung cancer usually occurs in smokers and often recurs after treatments that are currently available. (University of Kentucky photo) If you smoke and want to quit, ...
New research suggests heavy marijuana smoking may raise the risk of lung cancer risk, as well as head and neck cancer.
Add Yahoo as a preferred source to see more of our stories on Google. Dr. Zhonglin Hao says small cell lung cancer usually occurs in smokers and often recurs after treatments that are currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results